Eteri Tsetskhladze, MD, PhD, FESC, FACC
Vice President, General Medicine Medical Lead, Medical Affairs
A member of the Worldwide Clinical Trials team for more than 15 years, Eteri Tsetskhladze, MD, PhD, FESC, FACC, is currently Vice President, General Medicine Medical Lead, Medical Affairs. As a physician, she combines scientific and clinical rigor with an intimate understanding of the patient’s experience. As an educator, she is adept at translating medical and scientific findings into accessible data to serve commercial and regulatory objectives. Based in Tbilisi, Georgia, she currently oversees Worldwide’s Cardiometabolic and Renal, General Medicine, Rare Disease, and Early Phase franchises.
ABOUT ETERI TSETSKHLADZE, MD, PhD, FESC, FACC
As a clinician, investigator, and educator, Dr. Tsetskhladze embodies Worldwide’s commitment to supporting improved health care options. Since joining the Worldwide Clinical Trials team in 2004, she has supported more than 70 studies. In her capacity as medical director and therapeutic advisor, she has overseen work on such indications as cardiology, metabolic disorders, nephrology, chronic inflammatory diseases, rare diseases, pulmonology, and endocrinology. She has combined her therapeutic expertise with a commitment to education, serving as Clinical Professor of Medicine at State Medical University, as well as Chief Physician of the Department of General Cardiology at the State Medical University Hospital in Tbilisi, Georgia. Dr. Tsetskhladze is a fellow of the American College of Cardiology (ACC) and the European Society of Cardiology (ESC), while also serving on a number of therapeutic working groups. She is credited with more than 50 publications, including articles, book chapters, monographs, presentations, and invited lectures. A member of the Worldwide team for more than 15 years, she currently serves as Vice President, General Medicine Medical Lead, Medical Affairs, overseeing our Cardiometabolic and Renal, General Medicine, Rare Disease, and Early Phase franchises. When advising on the development of new chemical entities and novel treatment approaches, she uses her medical expertise to provide the therapeutic context required to support business development, regulatory compliance, and commercial objectives.
Dr. Tsetskhladze holds a Medical Degree with Distinction, as well as a PhD in clinical cardiology, from Tbilisi State Medical University.